What’s Vulnerable › Vulnerabilities
CVE-2025-61940: Mirion Medical EC2 Software NMIS BioDose Use of Client-Side Authentication
- Severity: high (CVSS 8.8 v3.1)
- Exploited in the wild: not listed in CISA KEV
- EPSS: 0.3% probability of exploitation in the next 30 days
- Public exploit or detection template: none known
- Published: 2025-12-02 · updated 2026-09-25
- Weakness: CWE-603
Description
NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has access. The latest version of NMIS/BioDose introduces an option to use Windows user authentication with the database, which would restrict this database connection.
Affected products
- Mirion Biodose/Nmis: before 23.0 — fixed in 23.0
How to fix
Upgrade to a fixed version: Mirion Biodose/Nmis 23.0. Check the vendor advisory for mitigations.
References
Get alerted when CVE-2025-61940 or the next vulnerability affects your stack